The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
After finishing at $17.41 in the prior trading day, Beam Therapeutics Inc (NASDAQ: BEAM) closed at $18.24, up 4.77%. In other words, the price has increased by $4.77 from its previous closing price. On the day, 2.23 million shares were traded.
Ratios:
Our goal is to gain a better understanding of BEAM by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 8.81 and its Current Ratio is at 8.81. In the meantime, Its Debt-to-Equity ratio is 0.14 whereas as Long-Term Debt/Eq ratio is at 0.13.
On March 10, 2025, Scotiabank Upgraded its rating to Sector Outperform which previously was Sector Perform but kept the price unchanged to $40.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Apr 01 ’25 when Bellon Christine sold 5,674 shares for $18.35 per share. The transaction valued at 104,122 led to the insider holds 117,294 shares of the business.
Evans John M. sold 30,663 shares of BEAM for $562,684 on Apr 01 ’25. The CEO now owns 986,249 shares after completing the transaction at $18.35 per share. On Apr 01 ’25, another insider, Ciaramella Giuseppe, who serves as the President of the company, sold 7,434 shares for $18.35 each. As a result, the insider received 136,418 and left with 190,216 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 28.85 while its Price-to-Book (P/B) ratio in mrq is 1.63.
Stock Price History:
Over the past 52 weeks, BEAM has reached a high of $35.25, while it has fallen to a 52-week low of $13.52. The 50-Day Moving Average of the stock is -11.08%, while the 200-Day Moving Average is calculated to be -26.11%.
Shares Statistics:
A total of 100.56M shares are outstanding, with a floating share count of 85.97M. Insiders hold about 14.51% of the company’s shares, while institutions hold 73.22% stake in the company.
